comprehensive -WSS

comprehensive

author：leisure time 2025-10-04 04:01:20 - browse：4563

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida – politics and policy coverage from STAT — Regeneron agreed to price limits for a new Covid-19 drug that will be developed in partnership with the Department of Health and Human Services. CHANDAN KHANNA/AFP via Getty Images

WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.

The contract between Regeneron and the government requires that the list price for a future monoclonal antibody drug to prevent Covid-19 is the same or lower in the United States as in other high-income countries. The release doesn’t explain which countries the government will be comparing prices with, or how pricing data will be determined.

The deal was part of the White House’s Project NextGen initiative, which includes $5 billion in new vaccines and therapies. HHS announced that it is spending $326 million to help Regeneron develop a new monoclonal antibody to prevent Covid-19. Regeneron in January announced plans to start testing a potentially variant-proof antibody, which is set to go into clinical trials later this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Being 'nonadherent' patient made me a more empathetic doctor

focus

WSS

Skip the lead apron during X

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Can food be medicine? And other questions about a new push

'Screen and refer' systems are hurting patients

New case study details death in closely watched Alzhiemer's trial

'Screen and refer' systems are hurting patients

entertainment

comprehensive

hotspot

Alkermes shareholders re

Can food be medicine? And other questions about a new push

Supreme Court strikes down use of affirmative action

Beware reading your test results before your doctor does

DIEP, the 'gold standard' of breast reconstruction, is under threat

'Screen and refer' systems are hurting patients

Walensky prepares to leave CDC — and Congress — behind

UpToDate has a racism problem: Dr. Stanley Goldfarb

Tori Bowie and the unacceptable rates of Black maternal death

Undocumented workers face uncertainty as immigration law takes effect in Florida

entertainment

4th of July breaks record for highest global temperature ever measured

Bacterial infection may be ‘key event’ in endometriosis, study says

UpToDate has a racism problem: Dr. Stanley Goldfarb

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

entertainment

hotspot

focus

Wikipedia